Hormones are natural substances produced by glands in our bodies. They are carried in our bloodstream and act as messengers between one part of our body and another. Hormone therapy for cancer is the use of medicines to block the effects of hormones which are used by some of the cancers to grow. Cancer hormone therapy does not work for all types of cancer. However doctors and surgeons use hormone therapy for people with cancers that are hormone sensitive or hormone dependent.
This report identifies the cancer hormone therapy market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to cancer hormone therapy market.
Globally North America dominated the market for cancer hormone therapy in 2015 due to higher usage of the latest and advanced technologies for treatment and high awareness and reported instances of cancer in the region. North America is expected to continue its domination during the period of study and was followed by Europe and Asia-Pacific as the second and third largest markets respectively in 2015. However Asia-Pacific is expected to be the fastest growing market due to technological advancement in the field of medical science, increasing medical tourism coupled with increasing awareness about cancer in the region.
This report on cancer hormone therapy also covers different type of cancer hormone therapy available, various cancer treated and market size in various geographical regions.
- On the basis of type of cancer hormone therapy this report classifies as follows covering all major types of cancer hormone therapy available in the market: Neoadjuvant treatment and Adjuvant treatment
- On the basis of cancer treated with cancer hormone therapy this report covers all the major cancer treated using cancer hormone therapy: Breast Cancer, Prostate Cancer, Ovarian Cancer, Thyroid Cancer and Others
- This report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for cancer hormone therapy in each of the region.
Sample Companies Profiled in this Report are:
- Novartis International AG
- AstraZeneca Plc
- Merck and Co.
- Pfizer Inc
- QuatRx Pharmaceuticals